Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Other(3)

Detailed Status

unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

not_yet_recruiting125%
unknown375%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

CPVI Alone Versus CPVI Plus Low-Voltage Areas Ablation During SR Versus CPVI Plus Low-Voltage Areas Ablation During AF for the Treatment of CAF

NCT06499818
unknownnot_applicable

CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF

NCT03448562
unknownnot_applicable

High-density Mapping-guided bOx Isolation and subsTrate Ablation

NCT03998956
unknownnot_applicable

CPVI Plus Renal Sympathetic Modification Versus CPVI Alone for AF（Atrial Fibrillation） Ablation

NCT01686542

Clinical Trials (4)

Showing 4 of 4 trials
NCT06499818Not Applicable

CPVI Alone Versus CPVI Plus Low-Voltage Areas Ablation During SR Versus CPVI Plus Low-Voltage Areas Ablation During AF for the Treatment of CAF

Not Yet Recruiting
NCT03448562Not Applicable

CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF

Unknown
NCT03998956Not Applicable

High-density Mapping-guided bOx Isolation and subsTrate Ablation

Unknown
NCT01686542Not Applicable

CPVI Plus Renal Sympathetic Modification Versus CPVI Alone for AF（Atrial Fibrillation） Ablation

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4